Deregulation of the EGFR/pI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

Giuseppe Montalto, Melchiorre Cervello, Alberto M. Martelli, Melissa Sokolosky, Kristin Stadelman, Joanna Dulinska-Litewka, Timothy L. Fitzgerald, Saverio Candido, Ferdinando Nicoletti, Nicole M. Davis, Joerg Basecke, Agnieszka Gizak, Danijela Maksimovic-Ivanic, Jerry Polesel, Sanja Mijatovic, Zoya N. Demidenko, Lyudmyla Drobot, Dariusz Rakus, Antonino D'Assoro, Massimo LibraLinda S. Steelman, Roberta Maestro, Piotr Laidler, James A. Mccubrey, Lucio Cocco, Giuseppe Montalto, Steve L. Abrams

Research output: Contribution to journalArticle

147 Citations (Scopus)
Original languageEnglish
Pages (from-to)4603-4650
Number of pages48
JournalOncotarget
Volume5
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Montalto, G., Cervello, M., Martelli, A. M., Sokolosky, M., Stadelman, K., Dulinska-Litewka, J., Fitzgerald, T. L., Candido, S., Nicoletti, F., Davis, N. M., Basecke, J., Gizak, A., Maksimovic-Ivanic, D., Polesel, J., Mijatovic, S., Demidenko, Z. N., Drobot, L., Rakus, D., D'Assoro, A., ... Abrams, S. L. (2014). Deregulation of the EGFR/pI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. Oncotarget, 5, 4603-4650.